Net Change In Cash - Xeris Biopharma Holdings Inc (NASDAQ:XERS) - Alpha Spread

Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 2.965 USD -0.5% Market Closed
Market Cap: 439.6m USD
Have any thoughts about
Xeris Biopharma Holdings Inc?
Write Note

Xeris Biopharma Holdings Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xeris Biopharma Holdings Inc
Net Change in Cash Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Net Change in Cash
$11.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Change in Cash
$3.7B
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Net Change in Cash
-$2.1B
CAGR 3-Years
38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Change in Cash
-$1.6B
CAGR 3-Years
N/A
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Change in Cash
$5.7B
CAGR 3-Years
N/A
CAGR 5-Years
33%
CAGR 10-Years
N/A
Eli Lilly and Co
NYSE:LLY
Net Change in Cash
$529.1m
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Xeris Biopharma Holdings Inc's Net Change in Cash?
Net Change in Cash
11.2m USD

Based on the financial report for Jun 30, 2024, Xeris Biopharma Holdings Inc's Net Change in Cash amounts to 11.2m USD.

Back to Top